Catalyst
Slingshot members are tracking this event:
Jaguar Animal Health Announces Positive Topline Results of University Study of Second-Generation Formulation of Neonorm Calf and Commercialization Strategy Updates
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
JAGX |
|
|
Additional Information
The double-blind, randomized study conducted in association with Cornell involved 40 Holstein bull calves that were affected with naturally occurring diarrhea. The study compared prophylactic use of Neonorm™ Calf against a placebo, administered twice daily. Data regarding fecal dry matter (“FDM”) was used to measure water loss due to secretory diarrhea. Body weight measurements were performed daily to determine average daily weight gain during the 25-day study. Blood and fecal samples were also collected, along with data related to bacterial genus prevalence in the intestinal microbiome.
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 17, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Neonorm, Diarrhea, Double-blind, Hydration, Fdm, Secretory Diarrhea